vs
Quanex Building Products CORP（NX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Quanex Building Products CORP的1.6倍（$772.1M vs $495.3M），Revvity净利率更高（12.7% vs -55.7%，领先68.5%），Quanex Building Products CORP同比增速更快（76.7% vs 5.9%），Revvity自由现金流更多（$161.8M vs $46.2M），过去两年Quanex Building Products CORP的营收复合增速更高（29.5% vs 9.0%）
Quanex Building Products是一家工程建筑组件及材料制造商，核心产品包括中空玻璃间隔条、门窗系统、橱柜及家具部件，服务北美、欧洲的住宅及商业建筑市场，主打节能可持续的建筑解决方案。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NX vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.6倍
$495.3M
营收增速更快
NX
高出70.8%
5.9%
净利率更高
RVTY
高出68.5%
-55.7%
自由现金流更多
RVTY
多$115.6M
$46.2M
两年增速更快
NX
近两年复合增速
9.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $495.3M | $772.1M |
| 净利润 | $-276.0M | $98.4M |
| 毛利率 | 27.9% | — |
| 营业利润率 | -54.7% | 14.5% |
| 净利率 | -55.7% | 12.7% |
| 营收同比 | 76.7% | 5.9% |
| 净利润同比 | -1188.8% | 3.9% |
| 每股收益（稀释后） | $-6.04 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXRVTY
| Q4 25 | — | $772.1M | ||
| Q3 25 | $495.3M | $698.9M | ||
| Q2 25 | $452.5M | $720.3M | ||
| Q1 25 | $400.0M | $664.8M | ||
| Q4 24 | $492.2M | $729.4M | ||
| Q3 24 | $280.3M | $684.0M | ||
| Q2 24 | $266.2M | $691.7M | ||
| Q1 24 | $239.2M | $649.9M |
净利润NXRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $-276.0M | $46.7M | ||
| Q2 25 | $20.5M | $53.9M | ||
| Q1 25 | $-14.9M | $42.2M | ||
| Q4 24 | $-13.9M | $94.6M | ||
| Q3 24 | $25.4M | $94.4M | ||
| Q2 24 | $15.4M | $55.4M | ||
| Q1 24 | $6.2M | $26.0M |
毛利率NXRVTY
| Q4 25 | — | — | ||
| Q3 25 | 27.9% | 53.6% | ||
| Q2 25 | 29.0% | 54.5% | ||
| Q1 25 | 23.1% | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.3% | 56.3% | ||
| Q2 24 | 24.9% | 55.7% | ||
| Q1 24 | 21.5% | 54.6% |
营业利润率NXRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | -54.7% | 11.7% | ||
| Q2 25 | 9.0% | 12.6% | ||
| Q1 25 | -1.7% | 10.9% | ||
| Q4 24 | 0.6% | 16.3% | ||
| Q3 24 | 8.4% | 14.3% | ||
| Q2 24 | 7.8% | 12.4% | ||
| Q1 24 | 3.3% | 6.8% |
净利率NXRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | -55.7% | 6.7% | ||
| Q2 25 | 4.5% | 7.5% | ||
| Q1 25 | -3.7% | 6.4% | ||
| Q4 24 | -2.8% | 13.0% | ||
| Q3 24 | 9.0% | 13.8% | ||
| Q2 24 | 5.8% | 8.0% | ||
| Q1 24 | 2.6% | 4.0% |
每股收益（稀释后）NXRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $-6.04 | $0.40 | ||
| Q2 25 | $0.44 | $0.46 | ||
| Q1 25 | $-0.32 | $0.35 | ||
| Q4 24 | $-0.52 | $0.77 | ||
| Q3 24 | $0.77 | $0.77 | ||
| Q2 24 | $0.46 | $0.45 | ||
| Q1 24 | $0.19 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.3M | $919.9M |
| 总债务越低越好 | $695.6M | — |
| 股东权益账面价值 | $717.4M | $7.3B |
| 总资产 | $2.0B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.97× | — |
8季度趋势，按日历期对齐
现金及短期投资NXRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | $66.3M | $931.4M | ||
| Q2 25 | $62.6M | $991.8M | ||
| Q1 25 | $50.0M | $1.1B | ||
| Q4 24 | $97.7M | $1.2B | ||
| Q3 24 | $94.0M | $1.2B | ||
| Q2 24 | $56.1M | $2.0B | ||
| Q1 24 | $44.4M | $1.7B |
总债务NXRVTY
| Q4 25 | — | — | ||
| Q3 25 | $695.6M | — | ||
| Q2 25 | $746.4M | — | ||
| Q1 25 | $725.2M | — | ||
| Q4 24 | $737.2M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.5M | — | ||
| Q1 24 | $61.6M | — |
股东权益NXRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | $717.4M | $7.4B | ||
| Q2 25 | $1.0B | $7.6B | ||
| Q1 25 | $972.1M | $7.6B | ||
| Q4 24 | $1.0B | $7.7B | ||
| Q3 24 | $594.1M | $7.9B | ||
| Q2 24 | $566.1M | $7.9B | ||
| Q1 24 | $555.0M | $7.8B |
总资产NXRVTY
| Q4 25 | — | $12.2B | ||
| Q3 25 | $2.0B | $12.1B | ||
| Q2 25 | $2.3B | $12.4B | ||
| Q1 25 | $2.2B | $12.4B | ||
| Q4 24 | $2.3B | $12.4B | ||
| Q3 24 | $872.5M | $12.8B | ||
| Q2 24 | $837.2M | $13.4B | ||
| Q1 24 | $813.4M | $13.4B |
负债/权益比NXRVTY
| Q4 25 | — | — | ||
| Q3 25 | 0.97× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.73× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.7M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $46.2M | $161.8M |
| 自由现金流率自由现金流/营收 | 9.3% | 21.0% |
| 资本支出强度资本支出/营收 | 2.9% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | $27.5M | $509.4M |
8季度趋势，按日历期对齐
经营现金流NXRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $60.7M | $138.5M | ||
| Q2 25 | $28.5M | $134.3M | ||
| Q1 25 | $-12.5M | $128.2M | ||
| Q4 24 | $5.5M | $174.2M | ||
| Q3 24 | $46.4M | $147.9M | ||
| Q2 24 | $33.1M | $158.6M | ||
| Q1 24 | $3.9M | $147.6M |
自由现金流NXRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $46.2M | $120.0M | ||
| Q2 25 | $13.6M | $115.5M | ||
| Q1 25 | $-24.1M | $112.2M | ||
| Q4 24 | $-8.2M | $149.8M | ||
| Q3 24 | $40.1M | $125.6M | ||
| Q2 24 | $25.5M | $136.6M | ||
| Q1 24 | $-5.7M | $129.7M |
自由现金流率NXRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | 9.3% | 17.2% | ||
| Q2 25 | 3.0% | 16.0% | ||
| Q1 25 | -6.0% | 16.9% | ||
| Q4 24 | -1.7% | 20.5% | ||
| Q3 24 | 14.3% | 18.4% | ||
| Q2 24 | 9.6% | 19.7% | ||
| Q1 24 | -2.4% | 20.0% |
资本支出强度NXRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 3.3% | 2.6% | ||
| Q1 25 | 2.9% | 2.4% | ||
| Q4 24 | 2.8% | 3.4% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 2.9% | 3.2% | ||
| Q1 24 | 4.0% | 2.7% |
现金转化率NXRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 1.39× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 1.83× | 1.57× | ||
| Q2 24 | 2.15× | 2.87× | ||
| Q1 24 | 0.62× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NX
| Window And Door Hardware | $150.3M | 30% |
| Screens | $76.8M | 16% |
| Window Profiles | $68.2M | 14% |
| Spacers | $54.7M | 11% |
| Wood Solutions | $53.4M | 11% |
| Seals And Gaskets | $29.9M | 6% |
| Access Solutions | $27.4M | 6% |
| Mixing Solution | $21.5M | 4% |
| Solar | $5.3M | 1% |
| Product Type Other | $3.3M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
